Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06PGZ
|
|||
Former ID |
DCL001240
|
|||
Drug Name |
Setrobuvir
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Hepatitis C virus infection [ICD-11: 1E51.1; ICD-10: B18.2] | Phase 2 | [1] | |
Company |
Anadys Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C25H25FN4O6S2
|
|||
Canonical SMILES |
CS(=O)(=O)NC1=CC2=C(C=C1)NC(=NS2(=O)=O)C3=C(C4C5CCC(C5)C4N(C3=O)CC6=CC=C(C=C6)F)O
|
|||
InChI |
1S/C25H25FN4O6S2/c1-37(33,34)28-17-8-9-18-19(11-17)38(35,36)29-24(27-18)21-23(31)20-14-4-5-15(10-14)22(20)30(25(21)32)12-13-2-6-16(26)7-3-13/h2-3,6-9,11,14-15,20,22,28,31H,4-5,10,12H2,1H3,(H,27,29)/t14-,15+,20+,22-/m0/s1
|
|||
InChIKey |
DEKOYVOWOVJMPM-RLHIPHHXSA-N
|
|||
CAS Number |
CAS 1071517-39-9
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Hepatitis C virus RNA-directed RNA polymerase (HCV NS5B) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Clinical pipeline report, company report or official report of Anadys Pharmaceuticals (2011). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.